VBIO
Price:
$0.28
Market Cap:
$896.27K
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Industry
Biotechnology
IPO Date
2021-11-11
Stock Exchange
NASDAQ
Ticker
VBIO
According to Valion Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 113.15K. This represents a change of -100.00% compared to the average of 223.79B of the last 4 quarters.
The mean historical Enterprise Value of Valion Bio, Inc. over the last ten years is 179.70B. The current 113.15K Enterprise Value has changed -99.99% with respect to the historical average. Over the past ten years (40 quarters), VBIO's Enterprise Value was at its highest in in the March 2019 quarter at 461.68B. The Enterprise Value was at its lowest in in the March 2026 quarter at 98.89M.
Average
179.70B
Median
93.23B
Minimum
47.12B
Maximum
448.56B
Discovering the peaks and valleys of Valion Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 80.21%
Maximum Annual Enterprise Value = 448.56B
Minimum Annual Increase = -15.84%
Minimum Annual Enterprise Value = 47.12B
| Year | Enterprise Value | Change |
|---|---|---|
| 2021 | 448.56B | 0.00% |
| 2020 | 448.56B | 54.06% |
| 2019 | 291.16B | 42.73% |
| 2018 | 204.00B | 70.12% |
| 2017 | 119.91B | 80.21% |
| 2016 | 66.54B | 7.10% |
| 2015 | 62.13B | 17.18% |
| 2014 | 53.02B | 12.54% |
| 2013 | 47.12B | -15.84% |
| 2012 | 55.98B | -13.67% |
The current Enterprise Value of Valion Bio, Inc. (VBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
396.10B
5-year avg
302.44B
10-year avg
179.70B
Valion Bio, Inc.’s Enterprise Value is less than Organicell Regenerative Medicine, Inc. (18.22M), less than OptiBiotix Health Plc (4.90M), less than Kadimastem Ltd (133.31M), less than OKYO Pharma Limited (48.33M), less than Vinergy Capital Inc. (20.39M), less than Sorrento Therapeutics, Inc. (111.15M), less than American Hemp Ventures, Inc. (0), less than Antisense Therapeutics Limited (0), greater than TPCO Holding Corp. (-8710833.00), less than Biofrontera AG (16.39M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 18.22M | $19.97M | |
| 4.90M | $20.06M | |
| 133.31M | $9.50M | |
| 48.33M | $22.73M | |
| 20.39M | $20.57M | |
| 111.15M | $16.54M | |
| 0 | $16.47M | |
| 0 | $19.64M | |
| -8710833.00 | $20.12M | |
| 16.39M | $19.35M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Valion Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Valion Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Valion Bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Valion Bio, Inc. (VBIO)?
What is the 3-year average Enterprise Value for Valion Bio, Inc. (VBIO)?
What is the 5-year average Enterprise Value for Valion Bio, Inc. (VBIO)?
How does the current Enterprise Value for Valion Bio, Inc. (VBIO) compare to its historical average?